Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Voyageur Pharmaceuticals ( (TSE:VM) ) has issued an announcement.
Voyageur Pharmaceuticals has signed a non-exclusive distribution agreement with Phalanx, a leading pharmaceutical distributor in Mexico, to expand its market presence in the Mexican healthcare sector. This partnership is a significant milestone in Voyageur’s international growth strategy, aiming to increase access to its barium-based contrast media products in Latin America, a region with growing demand for high-quality imaging solutions.
More about Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd. is a Canadian public company focused on developing cost-effective imaging contrast media products, specifically barium and iodine Active Pharmaceutical Ingredients (API). The company aims to vertically integrate the barium and iodine contrast markets and is also working on new endo fullerene drugs.
Average Trading Volume: 104,123
Technical Sentiment Signal: Hold
Current Market Cap: C$26.77M
See more insights into VM stock on TipRanks’ Stock Analysis page.